273 related articles for article (PubMed ID: 2538828)
1. Hepatitis B virus X gene can transactivate heterologous viral sequences.
Twu JS; Robinson WS
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2046-50. PubMed ID: 2538828
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
3. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.
Twu JS; Rosen CA; Haseltine WA; Robinson WS
J Virol; 1989 Jun; 63(6):2857-60. PubMed ID: 2724417
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis.
Twu JS; Wu JY; Robinson WS
Virology; 1990 Jul; 177(1):406-10. PubMed ID: 2191500
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of hepatitis B virus and human immunodeficiency virus sequence-promoted gene expression by cotransfected poly(I):poly(C).
Banerjee R; Price PM; Sung MW; Karpen S; Acs G
Virology; 1990 Nov; 179(1):410-5. PubMed ID: 2219731
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
Vacca A; Martinotti S; Screpanti I; Maroder M; Felli MP; Farina AR; Gismondi A; Santoni A; Frati L; Gulino A
J Biol Chem; 1990 May; 265(14):8075-80. PubMed ID: 2159467
[TBL] [Abstract][Full Text] [Related]
7. trans-activation of viral enhancers by the hepatitis B virus X protein.
Spandau DF; Lee CH
J Virol; 1988 Feb; 62(2):427-34. PubMed ID: 2826805
[TBL] [Abstract][Full Text] [Related]
8. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
Gendelman HE; Phelps W; Feigenbaum L; Ostrove JM; Adachi A; Howley PM; Khoury G; Ginsberg HS; Martin MA
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9759-63. PubMed ID: 2432602
[TBL] [Abstract][Full Text] [Related]
9. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
Neuveut C; Vigne R; Clements JE; Sire J
Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
[TBL] [Abstract][Full Text] [Related]
10. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.
Siddiqui A; Gaynor R; Srinivasan A; Mapoles J; Farr RW
Virology; 1989 Apr; 169(2):479-84. PubMed ID: 2705309
[TBL] [Abstract][Full Text] [Related]
11. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice.
Small JA; Bieberich C; Ghotbi Z; Hess J; Scangos GA; Clements JE
J Virol; 1989 May; 63(5):1891-6. PubMed ID: 2539492
[TBL] [Abstract][Full Text] [Related]
12. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function.
Yuh CH; Ting LP
J Virol; 1990 Sep; 64(9):4281-7. PubMed ID: 2166817
[TBL] [Abstract][Full Text] [Related]
13. Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells.
Shimazu T; Takada S; Ueno Y; Hayashi Y; Koike K
Genes Cells; 1998 Jul; 3(7):477-84. PubMed ID: 9753428
[TBL] [Abstract][Full Text] [Related]
14. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.
Hess JL; Small JA; Clements JE
J Virol; 1989 Jul; 63(7):3001-15. PubMed ID: 2542608
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.
Levrero M; Balsano C; Natoli G; Avantaggiati ML; Elfassi E
J Virol; 1990 Jun; 64(6):3082-6. PubMed ID: 2335828
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
Kashanchi F; Wood C
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
[TBL] [Abstract][Full Text] [Related]
17. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
18. Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription.
Tur-Kaspa R; Teicher L; Laub O; Itin A; Dagan D; Bloom BR; Shafritz DA
J Virol; 1990 Apr; 64(4):1821-4. PubMed ID: 2157063
[TBL] [Abstract][Full Text] [Related]
19. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.
Honigwachs J; Faktor O; Dikstein R; Shaul Y; Laub O
J Virol; 1989 Feb; 63(2):919-24. PubMed ID: 2911125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
